Epigenetic Reprogramming to Enhance Bone Regeneration in Type 2 Diabetes

Grant Project Details:

Awardee:
Elizabeth Bradley, PhD
Timeframe:
2022-2024
Location:
University of Minnesota | Minneapolis , MN
Amount:
$250,000
Status:
In Process
Explore all RMM grants awarded since inception

Grant timeline: proposal, updates, reports

Grant Location

University of Minnesota
Minneapolis , MN

Grant Description

Type 2 diabetes is a highly prevalent chronic condition that affects Minnesotans' quality of life while also imparting a significant financial burden. A number of co-morbidities are associated with type 2 diabetes, including increased systemic inflammation, elevated bone fracture risk and diminished bone healing; thus, reducing the body's own ability to heal. Our work suggests that epigenetic reprogramming of innate immune cells enhances bone healing in pre-clinical, non-diabetic models. In this application, we propose to evaluate the effects of epigenetic reprogramming to bone healing in a high fat diet (HFD)-induced model of type 2 diabetes. We will also determine if epigenetic programming limits enhanced commitment to bone resorbing osteoclasts observed in type 2 diabetes and if a novel regulator of cellular metabolism, Lipocalin 2, controls innate immune cell responses and glucose utilization.

Grant Awardee Biography

Dr. Bradley